1,510 results on '"Stein, Janet L."'
Search Results
52. Data from Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
53. Data from Runx2 Transcriptional Activation of Indian Hedgehog and a Downstream Bone Metastatic Pathway in Breast Cancer Cells
54. Supplementary Figure 2 from Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network
55. Supplementary Tables 1-10, Figures 1-6, Methods from Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression
56. Supplementary Methods from Integrin αvβ6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2
57. Supplementary Figure 1 from Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network
58. Supplementary Figure 1 from MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
59. Supplementary Figures 1 through 6 from Integrin αvβ6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2
60. Data from Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression
61. Supplementary Figure 2 from MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
62. Supplementary Figure Legends 1-5 from Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
63. Data from Integrin αvβ6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2
64. Supplementary Figure 3 from Runx2 Transcriptional Activation of Indian Hedgehog and a Downstream Bone Metastatic Pathway in Breast Cancer Cells
65. Supplementary Figure 1 from Runx2 Transcriptional Activation of Indian Hedgehog and a Downstream Bone Metastatic Pathway in Breast Cancer Cells
66. Supplementary Figure Legends 1-2 from MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
67. Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
68. Cbfβ Is a Novel Modulator Against Osteoarthritis by Maintaining Articular Cartilage Homeostasis Through TGF-Ꞵ Signaling
69. Ecosystem accounts define explicit and spatial trade-offs for managing natural resources
70. Cell Cycle Independent Interaction of CDC2 with the Centrosome, Which is Associated with the Nuclear Matrix-Intermediate Filament Scaffold
71. YY1 Regulates Vitamin D Receptor/Retinoid X Receptor Mediated Transactivation of the Vitamin D responsive Osteocalcin Gene
72. An AML-1 Consensus Sequence Binds an Osteoblast-Specific Complex and Transcriptionally Activates the Osteocalcin Gene
73. Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease
74. Intravenous Iron Sucrose Infusions Reducing Postpartum Blood Transfusion: A Quality Improvement Initiative
75. Biological and Molecular Effects of Vitamin D on Bone
76. MicroRNAs in the control of metastatic bone disease
77. Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells
78. Cell Cycle Control of Transcription at the G1/S Phase Transition
79. Biologic and Molecular Effects of Vitamin D on Bone
80. The Shared Core Resource as a Partner in Innovative Scientific Research: Illustration from an Academic Microscopy Imaging Center
81. Epigenetic Pathways Regulating Bone Homeostasis: Potential Targeting for Intervention of Skeletal Disorders
82. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2
83. A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program
84. Transcriptional Corepressor TLE1 Functions with Runx2 in Epigenetic Repression of Ribosomal RNA Genes
85. The Histone Gene Activator HINFP Is a Nonredundant Cyclin E/CDK2 Effector during Early Embryonic Cell Cycles
86. LB-036 - Cbfβ prevents articular cartilage degeneration.
87. Staged Assembly of Histone Gene Expression Machinery at Subnuclear Foci in the Abbreviated Cell Cycle of Human Embryonic Stem Cells
88. A microRNA Signature for a BMP2-Induced Osteoblast Lineage Commitment Program
89. Relation between Cord Blood Mercury Levels and Early Child Development in a World Trade Center Cohort
90. Phenotypic Transcription Factors Epigenetically Mediate Cell Growth Control
91. Runx2 Deficiency and Defective Subnuclear Targeting Bypass Senescence to Promote Immortalization and Tumorigenic Potential
92. Mitotic Retention of Gene Expression Patterns by the Cell Fate-Determining Transcription Factor Runx2
93. CXCR4 Mediates Enhanced Cell Migration in CALM-AF10 Leukemia
94. Adverse outcomes in early term versus full-term deliveries among higher-order cesarean births.
95. Cell Structure and the Regulation of Genes Controlling Proliferation and Differentiation: The Nuclear Matrix and Cytoskeleton
96. Runx2–smad signaling impacts the progression of tumor-induced bone disease
97. Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats)
98. Transcription of Histone H4, H3, and H1 Cell Cycle Genes: Promoter Factor HiNF-D Contains CDC2, Cyclin A, and an RB-Related Protein
99. Transcriptional Control of the Tissue-Specific, Developmentally Regulated Osteocalcin Gene Requires a Binding Motif for the Msx Family of Homeodomain Proteins
100. In vivo Occupancy of the Vitamin D Responsive Element in the Osteocalcin Gene Supports Vitamin D-Dependent Transcriptional Upregulation in Intact Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.